Ph1-positive acute leukemia (AL) cases show unique granules, distinct from Ph1-negative AL. This form of leukemia may be more resistant to chemotherapy and differs from chronic myelocytic leukemia (CML).
Area of Science:
Hematology
Oncology
Cytogenetics
Background:
Ph1-positive acute leukemia (AL) is a distinct subtype.
Understanding its unique characteristics is crucial for diagnosis and treatment.
Purpose of the Study:
To describe the clinical and cytogenetic features of Ph1-positive acute leukemia.
To identify pathognomonic markers and compare Ph1-positive AL with Ph1-negative AL and chronic myelocytic leukemia (CML).
Main Methods:
Case series analysis of 25 patients with Ph1-positive AL.
Cytogenetic studies for monitoring disease status.
Morphological examination of leukemic cells for specific granules.
Main Results:
13 cases of acute lymphocytic leukemia (ALL) and 12 of acute non-lymphocytic leukemia (ANLL) were identified.
Unique coarse, pink, peroxidase-negative cytoplasmic granules were observed in 12 cases, potentially pathognomonic for Ph1-positive AL.
Some patients achieved Ph1-negative status during remission.
Ph1-positive AL demonstrated greater resistance to chemotherapy compared to Ph1-negative AL.
Conclusions:
Coarse, pink, peroxidase-negative granules are a potential diagnostic marker for Ph1-positive acute leukemia.
Ph1-positive AL presents differently and responds less favorably to chemotherapy than Ph1-negative AL.
While sharing the Ph1 translocation with CML, Ph1-positive AL differs in age of onset and therapeutic response.